·Î°í
HOME CONTACT US
ȸ»ç¼Ò°³ °ÇÃà±â°è¼³ºñ°ø»ç ½ÅÀç»ý¿¡³ÊÁö(Áö¿­ ³Ã/³­¹æ) ä¿ëÁ¤º¸ °í°´¼¾ÅÍ ¹®ÀÇÇϱâ ÀÚ·á½Ç °øÁö»çÇ×
¹®ÀÇÇϱâ
ÀÚ·á½Ç
°øÁö»çÇ×
1:1 »ó´ã¸®½ºÆ®



  HOME > °í°´¼¾ÅÍ > ¹®ÀÇÇϱâ
Á¦¸ñ   wsvsQyyTaCeK
ÀÛ¼ºÀÚ   Mathew
ºñ¹Ð¹øÈ£   Á¶È¸¼ö   149
µî·ÏÀÏ   2019/08/21 (10:36)
³» ¿ë What are the hours of work? http://spankwire.in.net/ spank wire.com The treatment was developed with the US-based non-profit PATH Malaria Vaccine Initiative. David Kaslow, vice president, product development at PATH, said the limited efficacy of the vaccine must be put in context. There has been great progress with bed nets and other technical measures, "yet there is still a huge disease burden out there", he said. In that context, the vaccine has "a potentially significant public health impact". During the trials, he pointed out, there were 941 cases of malaria averted for every 1,000 children vaccinated.
¸®½ºÆ®·Î ´ä±Û´Þ±â ¼öÁ¤Çϱâ Áö¿ì±â
[°ü·ÃµÈ ±Û º¸±â]
42617 wsvsQyyTaCeK Mathe.. 2019.08.21 149

ȸ»ç¼Ò°³
°ÇÃ༳ºñ°ø»ç
½ÅÀç»ý¿¡³ÊÁö
¿À½Ã´Â±æ
(ÁÖ)º¸¶÷¿£Áö´Ï¾î¸µ
ȸ»ç¼Ò°³ ¿À½Ã´Â±æ e-mail
1998 BORAM-ENG company. All rights reserved
[143-220] ¼­¿ïƯº°½Ã ±¤Áø±¸ Á߰ 341-18       Tel : 02)3437-0901